EarningsQ3 2023 Earnings Report

ACADIA Pharmaceuticals (ACAD) Q3 2023 Earnings Report

0 Followers

MX:ACAD Q3 2023 EPS Results

Actual EPS-$7.23

Consensus EPS-$8.10

Beat/MissBeat by +$0.87

One Year Ago EPS-$3.07

Actual Revenue$3.83B

Expected Revenue$3.48B

Beat/MissBeat by +$350.32M

YoY Revenue Growth+61.96%

QuarterQ3 2023

Date11/02/2023

TimeAfter Close

Conference CallThursday, November 2, 2023

MX:ACAD Upcoming Earnings

ACADIA Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:ACAD Q3 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	3.58 / -	7.591	―
Aug 04, 2026	2026 (Q2)	1.23 / 3.25	2.892	12.50% (+0.36)
May 06, 2026	2026 (Q1)	0.92 / 0.36	1.988	-81.82% (-1.63)
Feb 25, 2026	2025 (Q4)	2.48 / 28.92	15.543	86.05% (+13.37)
Nov 05, 2025	2025 (Q3)	3.13 / 7.59	3.615	110.00% (+3.98)
Aug 06, 2025	2025 (Q2)	2.49 / 2.89	3.615	-20.00% (-0.72)
May 07, 2025	2025 (Q1)	1.57 / 1.99	1.807	10.00% (+0.18)
Feb 26, 2025	2024 (Q4)	3.90 / 15.54	5.061	207.14% (+10.48)
Nov 06, 2024	2024 (Q3)	2.49 / 3.61	-7.229	150.00% (+10.84)
Aug 06, 2024	2024 (Q2)	3.22 / 3.61	0.181	1900.00% (+3.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed